Analysis of dose-volume histogram parameters for radiation pneumonitis after definitive concurrent chemoradiotherapy for esophageal cancer

Radiotherapy and Oncology

Volumn 95, Issue 2, 2010, Pages 240-244

  Asakura, Hirofumi ^a   Hashimoto, Takayuki ^a   Zenda, Sadamoto ^a,b   Harada, Hideyuki ^a   Hirakawa, Koichi ^a,c   Mizumoto, Masashi ^a   Furutani, Kazuhisa ^a   Hironaka, Shuichi ^a   Fuji, Hiroshi ^a   Murayama, Shigeyuki ^a   Boku, Narikazu ^a   Nishimura, Tetsuo ^a  

^a SHIZUOKA CANCER CENTER   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^c SAGA UNIVERSITY   (Japan)

Author keywords

Chemoradiotherapy; Dose volume histogram; Esophageal cancer; Radiation pneumonitis

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CHEMORADIOTHERAPY; CLINICAL ARTICLE; DOSE VOLUME HISTOGRAM PARAMETER; ESOPHAGUS CANCER; FEMALE; HISTOGRAM; HUMAN; LUNG VOLUME; MALE; MEDICAL RECORD REVIEW; MULTIPLE CYCLE TREATMENT; PREDICTIVE VALUE; PREDICTOR VARIABLE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION PNEUMONIA; RADIOLOGICAL PARAMETERS; COMPUTER ASSISTED RADIOTHERAPY; ESOPHAGUS TUMOR; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; RADIATION RESPONSE;

AGED; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; RADIATION PNEUMONITIS; RADIOTHERAPY, CONFORMAL;

EID: 77956621987     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.02.006     Document Type: Article

References (22)

1. Graham MV, Purdy JA, Emami B, et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1999;45: 323-9. (Pubitemid 29408545)
2. Hernando ML, Marks LB, Bentel GC, et al. Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys 2001;51: 650-9.
3. Yorke ED, Jackson A, Rosenzweig KE, et al. Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 2002;54: 329-39. (Pubitemid 35286795)
4. Tsujino K, Hirota S, Endo M, et al. Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 2003;55: 110-5. (Pubitemid 36020349)
5. Claude L, Perol D, Ginestet C, et al. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis. Radiother Oncol 2004;71: 175-81. (Pubitemid 38521186)
6. Kim TH, Cho KH, Pyo HR, et al. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer. Radiology 2005;235: 208-15.
7. Wang S, Liao ZX, Wei X, et al. Analysis of clinical and dosimetric factors associated with treatment related pneumonitis (TRP) in patients with nonsmall- cell lung cancer (NSCLC) treated with concurrent chemotherapy (CCT) and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys 2006;66: 1399-407.
8. Rancati T, Ceresoli GL, Gagliardi G, Schipani S, Cattaneo GM. Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study. Radiother Oncol 2003;67: 275-83. (Pubitemid 36831080)
9. Fay M, Tan A, Fisher R, MacManus M, Wirth A, Ball D. Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 2005;61: 1355-63. (Pubitemid 40470415)
10. Kwa SL, Lebesque JV, Theuws JC, et al. Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 1998;42: 1-9. (Pubitemid 28435589)
11. Fu XL, Huang H, Bentel G, et al. Predicting the risk of symptomatic radiationinduced lung injury using both the physical and biologic parameters V(30) and transforming growth factor beta. Int J Radiat Oncol Biol Phys 2001;50: 899-908. (Pubitemid 32594832)
12. Schallenkamp JM, Miller RC, Brinkmann DH, Foote T, Garces YI. Incidence of radiation pneumonitis after thoracic irradiation: dose-volume correlates. Int J Radiat Oncol Biol Phys 2007;67: 410-6. (Pubitemid 46108327)
13. Chang DT, Olivier KR, Morris CG, et al. The impact of heterogeneity correction on dosimetric parameters that predict for radiation pneumonitis. Int J Radiat Oncol Biol Phys 2006;65: 125-31.
14. Jin H, Tucker SL, Liu HH, et al. Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy. Radiother Oncol 2009;91: 427-32.
15. Dehing-Oberije C, De Ruysscher D, van Baardwijk A, Yu S, Rao B, Lambin P. The importance of patient characteristics for the prediction of radiation-induced lung toxicity. Radiother Oncol 2009;91: 421-6.
16. Kleinberg L, Forastiere AA. Chemoradiation in the management of esophageal cancer. J Clin Oncol 2007;25: 4110-7. (Pubitemid 47492955)
17. Berger B, Belka C. Evidence-based radiation oncology: oesophagus. Radiother Oncol 2009;92: 276-90.
18. Ishikura S, Nihei K, Ohtsu A, et al. Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 2003;21: 2697-702. (Pubitemid 46606313)
19. Wang SL, Liao Z, Vaporciyan AA, et al. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 2006;64: 692-9. (Pubitemid 43183562)
20. Akobeng AK. Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr 2007;96: 644-7. (Pubitemid 46653167)
21. Wang S, Liao Z, Wei X, et al. Association between systemic chemotherapy before chemoradiation and increased risk of treatment-related pneumonitis in esophageal cancer patients treated with definitive chemoradiotherapy. J Thorac Oncol 2008;3: 277-82. (Pubitemid 351654328)
22. Japan Esophageal Society. Comprehensive registry of esophageal cancer in Japan. Available at http: //esophagus.jp/crec.html.